Apolipoprotein A-II polymorphism and visceral adiposity in African-American and white women

Obesity Research

Volumn 13, Issue 3, 2005, Pages 507-512

  Lara Castro, Cristina ^a   Hunter, Gary R ^a   Lovejoy, Jennifer C ^b   Gower, Barbara A ^a   Fernández, José R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Abdominal fat; Body composition; Ethnicity; Genetics; Total body fat

Indexed keywords

APOLIPOPROTEIN A2;

ADIPOSE TISSUE; ADULT; ALLELE; ARTICLE; BODY COMPOSITION; CAUCASIAN; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HUMAN; LONGITUDINAL STUDY; MUTATION; NEGRO; PHENOTYPE; PREMENOPAUSE; RADIODENSITOMETRY; RADIOGRAPHY; VISCERA;

ADIPOSE TISSUE; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; APOLIPOPROTEIN A-II; BODY COMPOSITION; DENSITOMETRY, X-RAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; LONGITUDINAL STUDIES; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; PREMENOPAUSE; TOMOGRAPHY, X-RAY COMPUTED; VISCERA;

EID: 22844434875     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.53     Document Type: Article

References (12)

1. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes. 1997;46:456-62.
2. Conway JM, Yanovski SZ, Avila NA, Hubbard VS. Visceral adipose tissue differences in black and white women. Am J Clin Nutr. 1995;61:765-71.
3. Jones DW. What is the role of obesity in hypertension and target organ injury in African Americans? Am J Med Sci. 1999;317:147-51.
4. Lara-Castro C, Weinsier RL, Hunter GR, Desmond R. Visceral adipose tissue in women: longitudinal study of the effects of fat gain, time, and race. Obes Res. 2002;10:868-74.
5. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism. 1996;45:1119-24.
6. Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261:469-72.
7. Castellani LW, Goto AM, Lusis AJ. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes. 2001;50:643-51.
8. Weng W, Breslow JL. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci USA. 1996;93:14788-94.
9. Lilja HE, Soro A, Ylitalo K, et al. A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster. Atherosclerosis. 2002;164:103-11.
10. Fullerton SM, Clark AG, Weiss KM, et al. Sequence polymorphism at the human apolipoprotein All gene (APOA2): unexpected deficit of variation in an African-American sample. Hum Genet. 2002;111:75-87.
11. van't Hooft FM, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A. Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation. 2001;104:1223-8.
12. Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes. 1999;48:1175-82.